Medical Weight Loss for Bristol, Connecticut Residents
Bristol, Connecticut residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Bristol through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Bristol Residents Choose New Hope Weight Loss
Bristol patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Connecticut and beyond since 2020.
Medical weight loss for Bristol is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.
Bristol is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout downtown Bristol and the greater Hartford County area of central Connecticut. Spanish-speaking Bristol patients complete the entire program, intake, consultation, and follow-up, in Spanish with our bilingual team.
Like much of Connecticut, many people in Bristol want a physician-supervised weight-loss option without local waitlists or unclear pricing. Compounded medication arrives in discreet, cold-pack packaging at your Bristol address, usually within days.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Bristol
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Bristol
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Bristol address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Bristol
How do I get treatment from Bristol?
As a Bristol, Connecticut patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Bristol?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Bristol in cold-pack packaging, no lines and no drive.
How much does it cost for Bristol patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Bristol do you serve?
We serve patients from across Bristol by telehealth, including downtown Bristol and the greater Hartford County area of central Connecticut.
How is medication shipped to Bristol patients?
After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Bristol address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Bristol, Connecticut by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.